Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins

  • Alonso Gardón, Marta
  • Elorza Vidal, Xabier
  • Castellanos, Aida
  • La Sala, Gina
  • Armand-Ugón, Mercedes
  • Gilbert, Alice
  • Di Pietro, Chiara
  • Pla Casillanis, Adrià
  • Ciruela Alférez, Francisco
  • Gasull Casanova, Xavier
  • Nunes Martínez, Virginia
  • Martínez, Albert
  • Schulte, Uwe
  • Cohen Salmon, Martine
  • Marazziti, Daniela
  • Estévez Povedano, Raúl
Megalencephalic Leukoencephalopathy with subcortical Cysts (MLC) is a type of vacuolating leukodystrophy, which is mainly caused by mutations in MLC1 or GLIALCAM. The two MLC-causing genes encode for membrane proteins of yet unknown function that have been linked to the regulation of different chloride channels such as the ClC-2 and VRAC. To gain insight into the role of MLC proteins, we have determined the brain GlialCAM interacting proteome. The proteome includes different transporters and ion channels known to be involved in the regulation of brain homeostasis, proteins related to adhesion or signaling as several G protein-coupled receptors (GPCRs), including the orphan GPRC5B and the proposed prosaposin receptor GPR37L1. Focusing on these two GPCRs, we could validate that they interact directly with MLC proteins. The inactivation of Gpr37l1 in mice upregulated MLC proteins without altering their localization. Conversely, a reduction of GPRC5B levels in primary astrocytes downregulated MLC proteins, leading to an impaired activation of ClC-2 and VRAC. The interaction between the GPCRs and MLC1 was dynamically regulated upon changes in the osmolarity or potassium concentration. We propose that GlialCAM and MLC1 associate with different integral membrane proteins modulating their functions and acting as a recruitment site for various signaling components as the GPCRs identified here. We hypothesized that the GlialCAM/MLC1 complex is working as an adhesion molecule coupled to a tetraspanin-like molecule performing regulatory effects through direct binding or influencing signal transduction events.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modelling physical resilience in ageing mice

  • Schosserer, Markus
  • Banks, Gareth
  • Dogan, Soner
  • Dungel, Peter
  • Fernandes, Adelaide
  • Marolt Presen, Darja
  • Matheu, Ander
  • Osuchowski, Marcin
  • Potter, Paul
  • Sanfeliu, Coral
  • Guvenc Tuna, Bilge
  • Varela-Nieto, Isabel
  • Bellantuono, Ilaria
Geroprotectors, a class of drugs targeting multiple deficits occurring with age, necessitate the development of new animal models to test their efficacy. The COST Action MouseAGE is a European network whose aim is to reach consensus on the translational path required for geroprotectors, interventions targeting the biology of ageing. In our previous work we identified frailty and loss of resilience as a potential target for geroprotectors. Frailty is the result of an accumulation of deficits, which occurs with age and reduces the ability to respond to adverse events (physical resilience). Modelling frailty and physical resilience in mice is challenging for many reasons. There is no consensus on the precise definition of frailty and resilience in patients or on how best to measure it. This makes it difficult to evaluate available mouse models. In addition, the characterization of those models is poor. Here we review potential models of physical resilience, focusing on those where there is some evidence that the administration of acute stressors requires integrative responses involving multiple tissues and where aged mice showed a delayed recovery or a worse outcome then young mice in response to the stressor. These models include sepsis, trauma, drug- and radiation exposure, kidney and brain ischemia, exposure to noise, heat and cold shock., This article is based upon work from COST Action (BM1402: MouseAGE), supported by COST (European Cooperation in Science and Technology) and European Union Research and Innovation Program Horizon 2020 (GrantAgreement Number 730879). This work was supported by the Austrian Research Fund (FWF: P30623-B26), the Spanish MINECO (SAF2016-77703), the European Regional Development Fund, and the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A quality framework for cryopreserved rodent disease models: INFRAFRONTIER quality principles in EMMA archiving and distribution

  • Ehlich, Hilke
  • Blease, Andrew
  • Biju, Reva
  • Gustems, Montse
  • Song, Fei
  • Fessele, Sabine
  • Massimi, Marzia
  • Bozonelos, Konstantinos
  • Ntafis, Vasileios
  • Hiltunen, Anniina E
  • Marschall, Susan
  • Stoeger, Claudia
  • Khorshidi, Zuzana
  • Ziadi, Abdelmalek
  • Jambou, Karine
  • Armagno, Arsenio
  • Scavizzi, Ferdinando
  • Raspa, Marcello
  • Fernández, Julia
  • Hierro, María Jesús del
  • Ayadi, Abdelkader
  • Pensavalle, Joelle
  • Prevost, Géraldine
  • Dufková, Lucie
  • Krupkova, Michaela
  • Nickl, Petr
  • Krimpenfort, Paul
  • van de Ven, Marieke
  • Jonkers, Jos
  • Valera Vázquez, Gema
  • Raess, Michael
  • Beckers, Johannes
  • Moles, Anna
  • Dahlhoff, Maik
  • Montoliu, Lluís
  • Hérault, Yann
  • Hinttala, Reetta
  • Kontoyiannis, Dimitris L
  • Sedlacek, Radislav
  • Hrabě de Angelis, Martin
  • Boersma, Auke A
  • Matteoni, Rafaele
The online version contains supplementary material available at https://doi.org/10.1007/s00335-025-10174-4., Ensuring the quality and reproducibility of biological resources is essential for advancing biomedical research and upholding animal welfare standards. The European Mouse Mutant Archive (EMMA), part of the INFRAFRONTIER research infrastructure, plays a key role in this effort by cryopreserving scientifically validated mutant mouse and rat strains and making them accessible to the global scientific community. To further enhance its processes and promote transparency, INFRAFRONTIER/EMMA has developed a set of ten Quality Principles specifically tailored to the unique requirements of cryopreserved rodent mutant strains. These principles guide EMMA's workflows by providing a structured yet flexible quality framework across its distributed nodes. They encompass both general standards-such as adherence to the 3Rs (Replace, Reduce, Refine), staff competence, and continuous improvement-and more specific areas including scientific evaluation, data curation, and intellectual property rights. Each principle is presented with contextual background, defined requirements, practical recommendations, and key references. This initiative aims to strengthen the reliability, ethical integrity, and reproducibility of preclinical research resources., ´This work has been funded by the European Union Research and Innovation programme Horizon 2020 (INFRAFRONTIER2020—Grant Agreement Number 730879) and has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101131669 (INFRAPLUS). PHENOMIN-TAAM is supported from French state funds through the "Agence Nationale de la Recherche" under the frame programme Investissements d’Avenir labelled ANR-10-INBS-07 PHENOMIN. The CCP (provided to RS) was financed by the Czech Academy of Sciences RVO 68378050, LM202303 and LM2018126 provided by MEYS CR, OP RDE CZ.02.1.01/0.0/0.0/16_013/0001789 (Upgrade of the Czech Centre for Phenogenomics: developing towards translation research by MEYS and ESIF). CSIC support for large European infrastructures, reference: INFRA23012 (to Lluis Montoliu) has been received. BSRC "Alexander Fleming" acknowledges support by ΙnfrafrontierGR / Phenotypos: The Greek Research Infrastructure for Molecular and Behavioral Phenotyping of biological model organisms for chronic degenerative diseases” (MIS 5002135). The Institute of Biochemistry and Cell Biology of Italian National Research Council (IBBC-CNR) is supported by “INFRAFRONTIER” and “MOUSE CLINIC MONTEROTONDO” annual funding (FOE) provided by the Italian Ministry of University and Research. The MRC National Mouse Archive, based at the Mary Lyon Centre at MRC Harwell, is supported by the UKRI Medical Research Council MC_UP_2201/2: MLC—Community Programmes award. For PHENOMIN-ICS, this work was supported by IdEx Unistra (ANR-10-IDEX-0002) and INBS PHENOMIN (ANR-10-INBS-07) under the framework of the French Investments for the Future Program. The Finnish EMMA node, Biocenter Oulu Transgenic and Tissue Phenotyping Core Facility, is supported by University of Oulu, Biocenter Finland, and Research Council of Finland, decision no 367712., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of the GlialCAM interactome: the G protein-coupled receptors GPRC5B and GPR37L1 modulate megalencephalic leukoencephalopathy proteins

  • Alonso Gardón, Marta
  • Elorza Vidal, Xabier
  • Castellanos, Aida
  • La Sala, Gina
  • Armand-Ugón, Mercedes
  • Gilbert, Alice
  • Di Pietro, Chiara
  • Pla Casillanis, Adrià
  • Ciruela Alférez, Francisco
  • Gasull Casanova, Xavier
  • Nunes Martínez, Virginia
  • Martínez, Albert
  • Schulte, Uwe
  • Cohen Salmon, Martine
  • Marazziti, Daniela
  • Estévez Povedano, Raúl
Megalencephalic Leukoencephalopathy with subcortical Cysts (MLC) is a type of vacuolating leukodystrophy, which is mainly caused by mutations in MLC1 or GLIALCAM. The two MLC-causing genes encode for membrane proteins of yet unknown function that have been linked to the regulation of different chloride channels such as the ClC-2 and VRAC. To gain insight into the role of MLC proteins, we have determined the brain GlialCAM interacting proteome. The proteome includes different transporters and ion channels known to be involved in the regulation of brain homeostasis, proteins related to adhesion or signaling as several G protein-coupled receptors (GPCRs), including the orphan GPRC5B and the proposed prosaposin receptor GPR37L1. Focusing on these two GPCRs, we could validate that they interact directly with MLC proteins. The inactivation of Gpr37l1 in mice upregulated MLC proteins without altering their localization. Conversely, a reduction of GPRC5B levels in primary astrocytes downregulated MLC proteins, leading to an impaired activation of ClC-2 and VRAC. The interaction between the GPCRs and MLC1 was dynamically regulated upon changes in the osmolarity or potassium concentration. We propose that GlialCAM and MLC1 associate with different integral membrane proteins modulating their functions and acting as a recruitment site for various signaling components as the GPCRs identified here. We hypothesized that the GlialCAM/MLC1 complex is working as an adhesion molecule coupled to a tetraspanin-like molecule performing regulatory effects through direct binding or influencing signal transduction events.